EODData

FRA, DC4: DexCom Inc

03 Sep 2025
LAST:

63.43

CHANGE:
 0.84
OPEN:
63.43
HIGH:
63.43
ASK:
0.00
VOLUME:
145
CHG(%):
1.31
PREV:
64.27
LOW:
63.43
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 2563.4363.4363.4363.43145
02 Sep 2564.1764.2764.0064.27145
01 Sep 2563.9664.4463.9664.4412
29 Aug 2564.0264.0264.0264.02100
28 Aug 2565.4865.4865.4865.48100
27 Aug 2565.3065.3065.3065.30100
26 Aug 2565.2165.2565.2165.25100
25 Aug 2569.8369.8369.8369.8330
22 Aug 2569.2769.2769.2769.2730
21 Aug 2569.8869.8869.8869.8830

COMPANY PROFILE

Name:DexCom Inc
About:DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Sector:Healthcare
Address:6340 Sequence Drive, San Diego, CA, United States, 92121
Website:https://www.dexcom.com/global
ISIN:US2521311074
LEI:549300YSK3QDSFR5EU59

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:52.42
Price to Book:11.48
Price to Sales:5.80
EBITDA:923.3M
Shares:392.16M
Market Cap:24.874B

TECHNICAL INDICATORS

MA5:64.33
MA10:66.12
MA20:66.96
MA50:69.88
MA100:70.43
MA200:72.71
RSI14:29.72
WPR14:-100.00
MTM14:-5.71
ROC14:-0.08
ATR:0.83
Week High:65.48
Week Low:63.43
Month High:69.88
Month Low:63.43
Year High:86.90
Year Low:51.73
Volatility:26.00

RECENT SPLITS

Date Ratio
13 Jun 20224-1